Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changming Yu

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Emerging Microbes & Infections|July 2, 2024
A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2Hancong Sun, Lingyun Xia, Jianhua Li, et al.
Mabs|March 28, 2020
Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donorsPengfei Fan, Xiangyang Chi, Guodong Liu, et al.
Viruses|March 4, 2020
Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn ProteinMeng Hao, Guanying Zhang, Shengnan Zhang, et al.
NPJ Vaccines|October 27, 2023
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaquesTing Bian, Meng Hao, Xiaofan Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2025
Nasal delivery of secretory IgA confers enhanced neutralizing activity against Omicron variants compared to its IgG counterpartGuanying Zhang, Ping Huang, Hongyu Yuan, et al.
Cell Discovery|April 4, 2023
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variantsXiangyang Chi, Lingyun Xia, Guanying Zhang, et al.
Viruses|September 27, 2025
Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp)Pu Fan, Peng Lv, Sen Zhang, et al.
International Journal of Biological Macromolecules|September 10, 2023
An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variantsWeihong Zeng, Xiaoying Jia, Xiangyang Chi, et al.
Clinical and Vaccine Immunology : CVI|March 20, 2015
Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen VaccineXiangyang Chi, Jianmin Li, Weicen Liu, et al.
Virology Journal|August 12, 2025
Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cellsJie Li, Shaoyan Wang, Yue Cui, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Emerging Microbes & Infections|July 2, 2024
A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2Hancong Sun, Lingyun Xia, Jianhua Li, et al.
Mabs|March 28, 2020
Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donorsPengfei Fan, Xiangyang Chi, Guodong Liu, et al.
Viruses|March 4, 2020
Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn ProteinMeng Hao, Guanying Zhang, Shengnan Zhang, et al.
NPJ Vaccines|October 27, 2023
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaquesTing Bian, Meng Hao, Xiaofan Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2025
Nasal delivery of secretory IgA confers enhanced neutralizing activity against Omicron variants compared to its IgG counterpartGuanying Zhang, Ping Huang, Hongyu Yuan, et al.
Cell Discovery|April 4, 2023
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variantsXiangyang Chi, Lingyun Xia, Guanying Zhang, et al.
Viruses|September 27, 2025
Licoflavone B Suppresses Influenza A Virus by Targeting the Viral RNA-Dependent RNA Polymerase (RdRp)Pu Fan, Peng Lv, Sen Zhang, et al.
International Journal of Biological Macromolecules|September 10, 2023
An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variantsWeihong Zeng, Xiaoying Jia, Xiangyang Chi, et al.
Clinical and Vaccine Immunology : CVI|March 20, 2015
Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen VaccineXiangyang Chi, Jianmin Li, Weicen Liu, et al.
Virology Journal|August 12, 2025
Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cellsJie Li, Shaoyan Wang, Yue Cui, et al.
Pageof 6